Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108017579A details metal-free quinoline synthesis via visible light. Offers high purity, mild conditions, and scalable supply chain solutions for global pharmaceutical manufacturers.
Novel visible-light driven synthesis method offers mild conditions and high purity for pharmaceutical intermediates, ensuring supply chain reliability and cost efficiency.
Novel photocatalyst-free method for high-purity homoallylamine intermediates using water and visible light, ensuring cost-effective and scalable manufacturing.
Patent CN113444041A details a mild, blue LED-driven route to quinolines. This metal-free process offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112812060B reveals a metal-free, visible-light driven arylation method for tetrahydroquinoline derivatives, offering green synthesis routes for pharmaceutical intermediates.
Novel photocatalytic route offers high purity and green manufacturing advantages for pharmaceutical intermediates supply chains globally.
Novel visible light method for deuterated aromatics using arylthianthrene salts. Metal-free, high yield, cost-effective for pharma intermediates.
Patent CN115403623A details a metal-free photocatalytic route for 2-pyrrolyl phosphine oxides, offering high yields and reduced costs for pharmaceutical manufacturing.
Patent CN113045479B details a green FeCl3-catalyzed route for 3-hydroxyisoindol-1-ones, offering cost-effective API intermediate manufacturing solutions.
Patent CN108129308A introduces visible light catalysis for ester synthesis offering green supply chain and cost advantages for pharmaceutical intermediate manufacturing processes globally.
Patent CN107353245B reveals metal-free photocatalytic route. Delivers high purity quinoline intermediates with significant supply chain and cost advantages for global buyers.
Discover a green, visible-light mediated method for synthesizing phosphorylated quinazolinone compounds. This novel route offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel photocatalytic carbene route for high-purity intermediates. Reduces steps and enhances supply chain reliability for global pharmaceutical and polymer manufacturers seeking cost reduction.
Patent CN117924125B details metal-free visible light synthesis for sulfonamide derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN105503742A reveals visible light photocatalysis for high-yield difluoroalkyl uracil synthesis offering supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN112390696B reveals a safe, metal-free method for alpha-aminonitrile synthesis using benzoyl cyanide and visible light, offering significant cost and safety advantages.
Novel photocatalytic method using acetone eliminates expensive metals. Ideal for API intermediates manufacturing with reduced costs and simplified supply chains.
Patent CN111253254A details a green CuCl2-catalyzed dichlorination method. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN111253254B details a mild visible light method for dichloride synthesis using CuCl2. This offers cost reduction in fine chemical manufacturing and reliable supply.
Novel photocatalytic synthesis route for high-purity phenanthridine derivatives. Green chemistry approach ensures cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.